Clinical Manifestations
Skin and mucosal
Oral ulcers (98%), which are usually painful, recurrent, and can involve the soft and hard palate, buccal mucosa, tongue, gingiva, lips, and tonsils, and usually heal without scarring
Genital ulcers (65%): recurrent, mostly heal with scarring, most commonly on scrotum in men and vulva or vagina in women
Orchiepididymitis (6%)
Skin lesion (75%), including pseudofolliculitis , acne-like papulopustular lesions, erythema nodosum , positive pathergy test
Joints (50%)
Ocular (50%): hypopyon , non-granulomatous panuveitis , retinal vasculitis
CNS involvement (10-30%): mesodiencephalic and brain-stem inflammation, encephalitis, meningitis, myelitis, neurocognitive dysfunction, cerebral-vein thrombosis
Cardiovascular
Arterial (2-18%): arterial aneurysms, arterial stenosis, arterial thrombosis
Cardiac (6%): valvulitis, myopericarditis, coronary arteritis
Venous (15-40%): DVT , superficial thrombophlebitis
Gastrointestinal (0-20%): mucosal ulcers, abdominal pain, hemorrhage, perforation
Diagnostic Criteria
ICBD 2014
Criteria:
Recurrent oral ulcers (2 points)
Genital ulcers (2 points)
Ocular lesions (2 points)
Skin lesions (1 point)
Vascular manifestations (1 point)
Neurologic manifestations (1 point)
Positive pathergy test (optional) (1 point)
Interpretation: diagnosis based on ≥4 points
Sensitivity 95%, specificity 92%
ISG 1990
Recurrent oral ulcerations (aphthous or herpetiform) at least three times in one year, plus
Any two of the following:
Sensitivity 95%, specificity 96%
Management
Isolated skin and mucosal ulcers: tropical treatments for active ulcers, with colchicine as preventative treatment
Refractory or widespread lesions or ulcers: prednisone 15 mg daily for 1 week, followed by a taper over several weeks
Other options for more advanced presentations include systemic glucocorticoids, azathioprine , TNF-α inhibitors ,
Further Reading